Markets
BSE See NSE See 27,257.64
21.98 (0.08%)
collapse Related Readings collapse

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

DSIJ
Mindshare

BSNL rolls out 1000 WIFI hotspots to counter 4G challenge

BSNL rolls out 1000 WIFI hotspots to counter 4G challenge

Amid the saga of revolutionary launch of Reliance Jio, the state-owned PSU, Bharat Sanchar Nigam Limited (BSNL) is all set to launch around 1000 high speed WIFI hotspots across the state of Kerala, the CGM of Kerala BSNL Circle announced in Thiruvananthapuram. He said, "This will be launched in a month and would give better speed than 4G."

Overnight Digest- Stocks to look out for on January 19

Overnight Digest- Stocks to look out for on January 19

The stocks which could see a significant movement either side on January 19 are KPIT Technologies, Sasken Communication, Alembic, Axis Bank, Yes Bank, DB Corp, Federal Bank, Ujjivan Financial Services, Yes Bank, Cipla, PNB and Tata Group stocks.

Q3FY17 Result : KPIT Technologies Ltd.

Q3FY17 Result : KPIT Technologies Ltd.

KPIT Technologies total sales for the December 2016 quarter came in at Rs 830.6 crore. This represents a 0.04 per cent sequential decline and 2.14 per cent YoY increase.

Trident stocks tumbles at 4.9 percent in Q3

Trident stocks tumbles at 4.9 percent in Q3

Trident, a manufacturer of terry towel, yarn and wheat straw-based paper, posted Q3FY17 results on January 18, 2017. Despite a positive opening, the stock tumbled at 4.9 per cent.

Metals shine to keep markets in the green

Metals shine to keep markets in the green

Indian capital markets opened on positive note, but the day’s gains were erased at the close of Wednesday’s session. Nifty rose above the 8450 level but could not sustain it on intra-day basis.

Pankaj Patel's Cadila receives approval from USFDA, stock sizzles

Pankaj Patel's Cadila receives approval from USFDA, stock sizzles

One of the leading pharmaceutical companies in India and also a global healthcare provider, Ahmedabad-based Zydus Cadila Healthcare has received a final approval from the US Food and Drug Administration (USFDA) to market Methotrexate Tablets USP, 2.5 mg.

Cabinet approves listing of public sector general insurance companies

Cabinet approves listing of public sector general insurance companies

The Cabinet of the Narendra Modi government approved on Wednesday listing of public sector general insurance companies through fresh equity, or through offer of sale or a mix of both. The news came in the middle of a market that remained in the green throughout the day.

Sterlite Technologies Ltd puts up stellar performance in Q3FY17.

Sterlite Technologies Ltd puts up stellar performance in Q3FY17.

Sterlite Technologies Ltd. reported its results for the quarter ended December 31, 2016 during market hours today. The company's total sales for Q3FY17 at Rs 732 crore represent a 32.85 per cent sequential increase and 22.82 per cent YoY increase.

Strengthening Tata's passenger car portfolio, Hexa hits the road

Strengthening Tata's passenger car portfolio, Hexa hits the road

The multinational automotive manufacturing company and a member of the Tata Group, the Tata Motors has launched its new flagship model, known as 'Tata Hexa' in India on January 18. The Hexa had been on Tata's drawing board for quite some time and has been designed by studios of three countries.

Quarterly Results: Phillips Carbon Black Ltd.

Quarterly Results: Phillips Carbon Black Ltd.

The standalone numbers showed robust growth on a sequential basis and stupendous growth when compared to the year ago period. The company's stock, which opened for trading at Rs. 255 on the BSE, has risen by 1.41 per cent after the results were declared and is currently trading around the Rs 255-mark.

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
Sanjay Kumar Jan 18 06:55PM
Buy infosys@950 in bulk
kumar aditya Jan 18 06:51PM
hey i m a new trader . i just want to ask that i had purchased sun pharma stock yesterday but it was sold automatically today . why? how can i purchase and retain my stock as it as for sometime..
Sachin Kabs Jan 18 03:56PM
I AM BACK
mohan thakre Jan 18 03:15PM
buy century text
Beept fleck Jan 18 02:48PM
@varun which scrip?

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »